cositecan: Clinical Trials

3 trials of cositecan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 21Terminated 1

Follow cositecan: new trials by email Literature Review of cositecan trials Research Report on cositecan

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
Karenitecin, Valproic Acid - Malignant Melanoma
Phase 1 / Phase 2TerminatedH. Lee Moffitt Cancer Center and Research Institute422005-03-012013-11-25
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer
Karenitecin (BNP1350) - Carcinoma, Carcinoma, Non-Small-Cell Lung
Phase 1CompletedBioNumerik Pharmaceuticals, Inc.322004-05-012020-03-12
Karenitecin in Treating Patients With Recurrent Malignant Glioma
karenitecin - Brain and Central Nervous System Tumors
Phase 1CompletedNational Cancer Institute (NCI)2002-01-012008-07-24

Conditions studied

Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Central Nervous System Neoplasms (1)  ·  Glioblastoma (1)  ·  Gliosarcoma (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Oligodendroglioma (1)

Sponsors

BioNumerik Pharmaceuticals, Inc. (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)

Top investigators

Adil Daud, M.D. (1)  ·  Stuart A. Grossman, MD (1)